Individual and additive effects of neuromodulators on the slow components of afterhyperpolarization currents in layer V pyramidal cells of the rat medial prefrontal cortex.
The effects of 5-hydroxytryptamine (5-HT), noradrenaline (NA), dopamine (DA) and the muscarinic receptor agonist carbachol (CCh) on the voltage step-induced outward currents underlying afterhyperpolarization (AHP), consisting of a medium (I(mAHP)) and slow (I(sAHP)) component, were investigated in layer V pyramidal cells of the rat medial prefrontal cortex (mPFC). Whole-cell voltage clamp recordings were performed in vitro to quantitatively measure I(mAHP) and I(sAHP) and to examine their functional link to spike-frequency adaptation in the presence of agonists. CCh, 5-HT and NA all reduced the I(sAHP) and the spike adaptation, and, in some cells, replaced the I(sAHP) by the slow inward currents (I(sADP)) underlying the slow afterdepolarization (sADP). DA, however, failed to increase the frequency despite its comparable inhibition of the I(sAHP) over a range of concentrations. In order to test the neuromodulator agonists to see if they have additive actions on the I(sAHP), the effects of co-application of two agonists that increased spike-frequency, 5-HT+NA, 5-HT+CCh and CCh+NA, all at the concentration 30 microM were examined. Specific combinations that included CCh showed additive effects on the slow afterpolarization currents, possibly via both inhibition of I(sAHP) and generation of I(sADP). These findings suggest that neuromodulators have differential effects on the link between the I(sAHP) modulation and spike-frequency adaptation, and that they could exert additive effects on the slow aftercurrents following a strong excitation and, therefore, regulate the repetitive firing properties of the output cells of the rat mPFC.
Satake
Takahiro
T
Division of Neuropsychiatry, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, 683-8503 Tottori, Japan.
Mitani
Hideaki
H
Nakagome
Kazuyuki
K
Kaneko
Koichi
K
D000200:Action Potentials / Q000187:drug effects* / Q000502:physiology / Q000528:radiation effects; D000818:Animals; D000831:Animals, Newborn; D002118:Calcium / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D004357:Drug Synergism; D004558:Electric Stimulation / Q000379:methods; D066298:In Vitro Techniques; D009433:Neural Inhibition / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects; D018377:Neurotransmitter Agents / Q000494:pharmacology*; D018408:Patch-Clamp Techniques / Q000379:methods; D017397:Prefrontal Cortex / Q000166:cytology*; D017966:Pyramidal Cells / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar
D018377:Neurotransmitter Agents; D002118:Calcium